Items where authors include "Tazzyman, S."

Article

Saville, T.J., Colton, H., Jarju, S. et al. (9 more authors) (2024) Microfluidic qPCR for detection of 21 common respiratory viruses in children with influenza-like illness. Scientific Reports, 14 (1). 28292. ISSN 2045-2322

Tazzyman, S., Stewart, G.R., Yeomans, J. orcid.org/0000-0002-9546-3600 et al. (6 more authors) (2023) HSV1716 prevents myeloma cell regrowth when combined with bortezomib in vitro and significantly reduces systemic tumor growth in mouse models. Viruses, 15 (3). 603. ISSN 1999-4915

Paton-Hough, J., Tazzyman, S., Evans, H. et al. (6 more authors) (2019) Preventing and repairing myeloma bone disease by combining conventional antiresorptive treatment with a bone anabolic agent in murine models. Journal of Bone and Mineral Research, 34 (5). pp. 783-796. ISSN 0884-0431

Keklikoglou, I., Cianciaruso, C., Güç, E. et al. (16 more authors) (2019) Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nature Cell Biology, 21 (2). pp. 190-202. ISSN 1465-7392

Brown, H.K., Schiavone, K., Tazzyman, S. et al. (2 more authors) (2017) Zebrafish xenograft models of cancer and metastasis for drug discovery. Expert Opinion on Drug Discovery, 12 (4). pp. 379-389. ISSN 1746-0441

Widziolek, M., Prajsnar, T.K., Tazzyman, S. et al. (3 more authors) (2016) Zebrafish as a new model to study effects of periodontal pathogens on cardiovascular diseases. Scientific Reports, 6. p. 36023. ISSN 2045-2322

Tazzyman, S., Richards, N., Trueman, A.R. et al. (6 more authors) (2015) Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial. BMJ Open Gastroenterology, 2. e000052. ISSN 2054-4774

Tazzyman, S., Murdoch, C., Yeomans, J. et al. (2 more authors) (2014) Macrophage-mediated response to hypoxia in disease. Hypoxia, 2. pp. 185-196.

Ogryzko, N.V., Hoggett, E.E., Solaymani-Kohal, S. et al. (4 more authors) (2014) Zebrafish tissue injury causes upregulation of interleukin-1 and caspase-dependent amplification of the inflammatory response. Disease Models & Mechanisms, 7 (2). pp. 259-264. ISSN 1754-8403

Krajewska, E., Lewis, C.E., Chen, Y.Y. et al. (3 more authors) (2010) A novel fragment derived from the beta chain of human fibrinogen, beta 43-63, is a potent inhibitor of activated endothelial cells in vitro and in vivo. British Journal of Cancer, 102 (3). pp. 594-601. ISSN 0007-0920